The etiology of obesity and type 2 diabetes is universally recognized as multifactorial with a complex interaction between genetic, individual, and environmental factors.

Clinical interventions, which typically focus on weight loss, reduction of obesity-related comorbidities, and change in dysfunctional behaviors, should be implemented in a multidisciplinary context with a clinical team composed of endocrinologists, nutritionists, dieticians, physiotherapists, psychiatrists, psychologists, and sometimes surgeons. Significant limitations in the multidisciplinary chronic care management of type 2 diabetes with obesity concern costs and long-term adherence and compliance. mHealth (also m-health, mhealth, or mobile health) could be defined as the practice of medicine and public health supported by mobile communication devices, such as mobile phones, tablet computers, and PDAs, for health services and information. mHealth could be useful also for type 1 diabetes that often needs rigorous daily routines and an enduring self-management.

Programs with mHealth platforms and new technologies could overcome limitations connected to the traditional in-patient chronic care management by providing promising opportunities for enhancing weight reduction and reducing complications in terms of long-term efficacy and effectiveness across clinical, organizational, and economic perspectives.

New technologies can help clinicians and motivate patients in maintaining significant lifestyle behavior changes, improving health outcomes, quality of life, and well-being, and ensuring functional patient empowerment and engagement.

Potential topics include, but are not limited to:

• mHealth applications for remote monitoring and management, biomedical sensors and devices, integrated platforms, and technologies in chronic care management of obesity and type 2 diabetes and type 1 diabetes
• mHealth solutions for changing lifestyles, promoting healthier behaviors, and enhancing motivation to change and patient's adherence-engagement-empowerment in obesity and type 2 diabetes and type 1 diabetes
• mHealth solutions for prevention and treatment of diabetes (i.e., blood glucose management, insulin administration, lifestyle education, etc.) improved via remote platforms
• mHealth solutions in specific healthcare settings such as remote areas, low income countries, and poor regions
• mHealth cost-effectiveness studies and projects
• Web, Internet, and telephone based clinical protocols, telemedicine, and eHealth applications in clinical psychology for obesity and type 2 diabetes and type 1 diabetes